ÂÜÀòÂÒÂ×

James Kranz is an experienced biopharmaceutical executive currently serving as Vice President and Head of CMC at Compass Therapeutics Inc., where responsibilities include overseeing the development and manufacturing of clinical-stage biopharmaceuticals. Previous roles include Vice President of Pharmaceutical and Analytical R&D at GreenLight Biosciences, Senior Director of Drug Product Development at Kiniksa Pharmaceuticals, and positions at GSK and Johnson & Johnson focusing on drug product development and small molecule drug discovery. James Kranz holds a Ph.D. in Molecular Biophysics from Washington University School of Medicine and completed postdoctoral studies at the University of Pennsylvania.